What causes eosinophilic asthma

What is Eosinophilic Asthma?

Eosinophilic asthma is a specific phenotype, or subtype, of asthma characterized by elevated levels of eosinophils in the airways. Eosinophils are a type of granulocyte, a white blood cell that plays a role in the immune system, particularly in fighting off certain infections and in allergic responses. In eosinophilic asthma, these cells become overactive and accumulate in the lining of the bronchial tubes. This accumulation leads to inflammation and swelling of the airways, increased mucus production, and bronchoconstriction (tightening of the airway muscles), all of which contribute to the characteristic symptoms of asthma.

Causes and Triggers of Eosinophilic Asthma

The exact cause of eosinophilic asthma is not fully understood, but it is believed to be a complex interplay of genetic predisposition and environmental factors. The key mechanism involves an overactive immune response that leads to the excessive production and recruitment of eosinophils to the lungs.

Allergic Triggers:

For many individuals with eosinophilic asthma, allergic reactions are significant triggers. When someone with a predisposition to allergies inhales an allergen, their immune system overreacts. This triggers the release of specific antibodies (IgE) and inflammatory mediators, including cytokines that attract eosinophils. Common allergens include:

• Pollen
• Dust mites
• Pet dander (from cats, dogs, etc.)
• Mold spores
• Certain foods (less common as a direct trigger for asthma symptoms but can contribute to allergic responses)

Exposure to these allergens can lead to a cascade of inflammatory events, culminating in the characteristic symptoms of an asthma exacerbation.

Non-Allergic Triggers:

While allergies are common, eosinophilic asthma can also be triggered by non-allergic factors, or a combination of both. These triggers can stimulate the inflammatory pathways that lead to eosinophil recruitment and activation:

• Viral Infections: Respiratory infections, such as the common cold or influenza, are potent triggers for asthma exacerbations in general, and can worsen eosinophilic inflammation.
• Irritants: Exposure to environmental irritants like cigarette smoke (including secondhand smoke), air pollution, strong perfumes, cleaning products, and chemical fumes can irritate the airways and provoke an inflammatory response.
• Weather Changes: Cold, dry air or sudden changes in temperature can trigger asthma symptoms in some individuals.
• Exercise: While exercise-induced bronchoconstriction is common in all asthma types, it can be a trigger for eosinophilic asthma as well.
• Medications: Certain medications, such as aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs), can trigger asthma symptoms in sensitive individuals (aspirin-exacerbated respiratory disease). Beta-blockers can also sometimes worsen asthma.

The Role of Eosinophils

Eosinophils are central to the pathology of this asthma subtype. Once recruited to the airways, they release granules containing cytotoxic proteins and inflammatory mediators. These substances can:

• Damage the airway epithelium (the lining of the airways).
• Promote mucus hypersecretion.
• Contribute to airway hyperresponsiveness (the airways become overly sensitive to stimuli).
• Play a role in airway remodeling, a long-term process where the airway walls thicken and airways narrow permanently.

The persistent presence and activity of eosinophils lead to chronic inflammation, which is why eosinophilic asthma is often considered a more severe and difficult-to-control form of asthma.

Diagnosis and Differentiation

Diagnosing eosinophilic asthma typically involves a combination of clinical assessment, lung function tests, and biological markers. A key diagnostic criterion is the measurement of eosinophil counts:

• Blood Eosinophil Count: A higher-than-normal eosinophil count in a blood sample (typically >300 cells/µL or >3% of total white blood cells) can suggest eosinophilic inflammation.
• Sputum Eosinophil Count: Examining a sample of coughed-up mucus (sputum) for eosinophils is a more direct measure of airway inflammation. A count of 3% or more eosinophils in sputum is often indicative of eosinophilic asthma.
• Fractional Exhaled Nitric Oxide (FeNO): Elevated FeNO levels, a marker of airway inflammation, can also be associated with eosinophilic asthma.

It's important to differentiate eosinophilic asthma from other asthma phenotypes, such as allergic asthma (which may have elevated IgE but not necessarily high eosinophils) or neutrophilic asthma (characterized by high neutrophil counts). This differentiation is crucial for guiding appropriate treatment strategies.

Treatment Implications

Understanding that eosinophils are driving the inflammation is key to effective management. Corticosteroids, both inhaled and oral, are the cornerstone of treatment because they suppress eosinophil activity and reduce inflammation. For severe eosinophilic asthma that is not well-controlled with standard therapies, biologic medications targeting specific inflammatory pathways involving eosinophils (e.g., antibodies against IL-5 or IL-5 receptor) have shown significant success in reducing exacerbations and improving symptom control.